In a research report issued April 30, Canaccord Genuity analyst John Newman reiterated a Buy rating on Celgene Corporation (NASDAQ:CELG) with a price target …
Kite Pharma Inc (NASDAQ:KITE) has been reiterated as a Buy at Canaccord Genuity by research analyst John Newman. The analyst reiterated a Buy rating on …
Canaccord Genuity’s healthcare analyst John Newman weighed in today with his views on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company reported that the FDA is requesting …
In a research report released Tuesday, Canaccord Genuity analyst John Newman maintained a Hold rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with an $8.00 price target, …
Canaccord Genuity’s healthcare analyst John Newman weighed in today with a few insights on Mast Therapeutics Inc (NYSEMKT:MSTX), as the company recently announced that, in a …
In a research report published Friday, Canaccord Genuity analyst John Newman maintained a Buy rating on Celgene Corporation (NASDAQ:CELG) with a price target …
Canaccord Genuity analyst John Newman was out pounding the table on Agios Pharmaceuticals (NASDAQ:AGIO) Tuesday, reiterating a Buy rating and a price target of …
In a research report issued today, Canaccord Genuity analyst John Newman maintained a Hold rating on Acelrx Pharmaceuticals (NASDAQ:ACRX) with an $8 price target, …
In a research report issued today, Canaccord Genuity analyst John Newman maintained a Buy rating on Lannett Company (NYSE:LCI) with a price target …
In a research report sent to investors today, Canaccord Genuity analyst John Newman maintained a Buy rating on Agios Pharma (NASDAQ:AGIO) and raised his …
